1. Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador
- Author
-
Yang Yu, Rodney S. Russell, Catherine Donovan, Laura Gilbert, Hedy Dalton-Kenny, Robert Needle, Sandy Hookey, Lei Jiao, George Zahariadis, and Peter Wang
- Subjects
Adult ,Male ,0301 basic medicine ,Adolescent ,Coronavirus disease 2019 (COVID-19) ,Hepatitis C virus ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Immunology ,Enzyme-Linked Immunosorbent Assay ,Antibodies, Viral ,medicine.disease_cause ,COVID-19 Serological Testing ,Serology ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Virology ,medicine ,Humans ,Aged ,Coronavirus ,Aged, 80 and over ,biology ,SARS-CoV-2 ,business.industry ,Middle Aged ,Viral Load ,Immunoglobulin A ,Immunoglobulin class ,030104 developmental biology ,Immunoglobulin G ,biology.protein ,Molecular Medicine ,Female ,030211 gastroenterology & hepatology ,Antibody ,business ,Viral load - Abstract
The ability to detect antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently under investigation with various performance characteristics and indications for use. In this article, we analyzed the ability of the Abbott SARS-CoV-2 immunoglobulin class G (IgG), EuroImmun SARS-CoV-2 enzyme-linked immunosorbent assay (ELISA) IgG, and EuroImmun SARS-CoV-2 ELISA immunoglobulin class A (IgA) kits to detect evidence of previous infection with SARS-CoV-2. We tested 49 known coronavirus disease-19 (COVID-19) patients and 111 prepandemic stored serology specimens. This resulted in a sensitivity of 95.9%, 100.0%, and 91.3% and a specificity of 98.2%, 98.2%, and 90.8% respectively, using manufacturer recommended cutoffs after inconclusive results (one for EuroImmun IgG and five for EuroImmun IgA) being excluded in the final statistical analyses. Cross-reactivity of hepatitis C virus seropositive specimens was observed resulting in false positives (p < 0.05). If a two-tiered algorithmic approach was applied, that is, testing with Abbott SARS-CoV-2 assay followed by EuroImmun SARS-CoV-2 IgG, 100% specificity and sensitivity could be obtained after six inconclusive results were excluded from data set before statistical analyses. Performance characteristics presented demonstrate the superior performance of IgG class antibodies for investigating previous infections. In addition, utilizing a second antibody test for supplementary testing may significantly enhance performance, particularly in lower prevalence settings.
- Published
- 2021